Government Affairs Strategies and Advice
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2020 | ATEA PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | — | |
| 2020 | ACCURAY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2020 | ATEA PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | — | |
| 2020 | ACCURAY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$30,000 | — | |
| 2020 | ACCURAY |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — | |
| 2020 | ATEA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — | |
| 2020 | ATEA PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) Registration |
— | — | |
| 2020 | ACCURAY |
2nd Quarter (Apr 1 - June 30) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| ACCURAY | 19 | $200,000 |
| ATEA PHARMACEUTICALS | 18 | $160,000 |
| Name | Disclosed Prior Position |
|---|---|
| BURT ROSEN | President, Burt Rosen Strategies |